Ye Zhi-Wei, Zhang Jie, Townsend Danyelle M, Tew Kenneth D
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 70 President St., DD410, Charleston, SC 29425, USA.
Department of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, 274 Calhoun Street MSC 141, Charleston, SC 29425-1410, USA.
Biochim Biophys Acta. 2015 Aug;1850(8):1607-21. doi: 10.1016/j.bbagen.2014.11.010. Epub 2014 Nov 15.
Within cells, there is a narrow concentration threshold that governs whether reactive oxygen species (ROS) induce toxicity or act as second messengers.
We discuss current understanding of how ROS arise, facilitate cell signaling, cause toxicities and disease related to abnormal cell differentiation and those (primarily) sulfur based pathways that provide nucleophilicity to offset these effects.
Cellular redox homeostasis mediates a plethora of cellular pathways that determine life and death events. For example, ROS intersect with GSH based enzyme pathways to influence cell differentiation, a process integral to normal hematopoiesis, but also affecting a number of diverse cell differentiation related human diseases. Recent attempts to manage such pathologies have focused on intervening in some of these pathways, with the consequence that differentiation therapy targeting redox homeostasis has provided a platform for drug discovery and development.
The balance between electrophilic oxidative stress and protective biomolecular nucleophiles predisposes the evolution of modern life forms. Imbalances of the two can produce aberrant redox homeostasis with resultant pathologies. Understanding the pathways involved provides opportunities to consider interventional strategies. This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.
在细胞内,存在一个狭窄的浓度阈值,该阈值决定了活性氧(ROS)是诱导毒性还是充当第二信使。
我们讨论了目前对ROS如何产生、促进细胞信号传导、导致与异常细胞分化相关的毒性和疾病以及那些(主要)基于硫的途径的理解,这些途径提供亲核性以抵消这些影响。
细胞氧化还原稳态介导了大量决定生死事件的细胞途径。例如,ROS与基于谷胱甘肽(GSH)的酶途径相互作用,影响细胞分化,这是正常造血过程中不可或缺的一个过程,但也会影响许多与细胞分化相关的人类疾病。最近针对此类病症的治疗尝试集中在干预其中一些途径上,结果是针对氧化还原稳态的分化疗法为药物发现和开发提供了一个平台。
亲电氧化应激与保护性生物分子亲核试剂之间的平衡促成了现代生命形式的进化。两者的失衡会导致氧化还原稳态异常,从而引发疾病。了解其中涉及的途径为考虑干预策略提供了机会。本文是名为“分化与去分化的氧化还原调节”的特刊的一部分。